Education
About Us
Working with TipRanks
Follow Us
Geron Corp (GERN)
NASDAQ:GERN
Earnings Data
Report Date
Nov 06, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.03Last Year’s EPS
-0.04Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a strong performance for RYTELO with significant revenue growth, team expansion, and promising clinical trial progress. However, challenges remain in data accuracy for patient usage, drug retention issues, and European commercialization uncertainties.Company Guidance
RYTELO Revenue Growth
Q2 RYTELO net revenues were $49 million, representing an increase of approximately 24% over the first quarter, driven by increased demand from new patient starts.
Expansion of Commercial and Medical Affairs Teams
The company expanded its commercial sales force and customer-facing roles by over 20% and doubled the size of its medical affairs organization, with all new hires now trained and deployed.
Strong Payer Access
Approximately 90% of U.S. covered lives are now under favorable RYTELO medical coverage policies, an increase from 85% in the first quarter.
European Market Strategy
Activities to support the launch of RYTELO in select EU markets next year are ongoing, with a focus on securing strong reimbursement rates.
IMpactMF Phase III Trial Progress
The IMpactMF trial is over 95% enrolled, with completion expected by year-end. The trial is the first MF trial with overall survival as the primary endpoint.
GERN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GERN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2025 | $1.20 | $1.39 | +15.83% |
May 07, 2025 | $1.32 | $1.31 | -0.76% |
Feb 26, 2025 | $2.37 | $1.61 | -32.07% |
Nov 07, 2024 | $4.27 | $4.29 | +0.47% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Geron Corp (GERN) report earnings?
Geron Corp (GERN) is schdueled to report earning on Nov 06, 2025, After Close (Confirmed).
What is Geron Corp (GERN) earnings time?
Geron Corp (GERN) earnings time is at Nov 06, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GERN EPS forecast?
GERN EPS forecast for the fiscal quarter 2025 (Q3) is -0.03.